MedTrace Logo

Toremifene in Treating Patients With Desmoid Tumors

NCT00002595 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2013-07-10

No results posted yet for this study

Summary

RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using toremifene may fight the growth of desmoid tumors by reducing the production of estrogen.

PURPOSE: Phase II trial to study the effectiveness of toremifene in treating patients with desmoid tumors.

Conditions

  • Desmoid Tumor

Interventions

DRUG

toremifene

PROCEDURE

conventional surgery

Sponsors & Collaborators

  • Advocate Lutheran General Hospital

    lead OTHER

Principal Investigators

  • Brian L. Samuels, MD · Advocate Lutheran General Hospital

Study Design

Purpose
TREATMENT

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-07-31
Primary Completion
2003-05-31
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002595 on ClinicalTrials.gov